Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Thomas Peterffy, founder and chairman of Interactive Brokers, discusses key topics in an interview with CNBC.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Thomas Peterffy, founder and chairman of Interactive Brokers
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Tan Sri Dato' Seri Vincent Tan, Founder and Advisor of Berjaya Corporation Berhad, was named the 2023 Malaysia Real Estate Personality of the Year.|Tan Sri Dato' Seri Vincent Tanis the founder of Berjaya Corporation Berhad
00:10:00
Arrow Minerals: Exploring Gold Potential in Australia and Burkina Faso
00:10:00
The New Fundraising Landscape|Kris Fredrickson,Managing Partner,Coatue
00:10:00
CEO Alan Trefler positions Pegasystems for the long game in customer-centric innovation and sustainable growth.|Alan Trefler is the Founder and CEO of Pegasystems Inc.,
00:10:00
Graphite Project Overview and Market Strategy
00:10:00
We're a team of former serial founders managing over $1.25B across a number of funds|Avi Eyal,Cofounder And Managing Partner, Entrée Capital
00:10:00
Astra Exploration CEO Brian Miller Discusses Potential of Pom Pasciencia Project in Northern Chile
00:10:00
Amit Yoran, CEO of Tenable, discusses the cybersecurity landscape in light of a recent surge in cyberattacks.
00:10:00
2024 Global Market Outlook – Q3 Update: Navigating the Three-Scenario Problem
00:10:00
Far Resources: Canadian Lithium Projects Overview
00:10:00
Global network and operational resources make us more valuable than capital alone|Reeta, Co-Founder,The Silverfern Group, Inc.
00:10:00
Jake's Take: Election Year Planning | Castlepoint Wealth Advisors